MSD to acquire Cidara after positive phase 2b trial results
27th November 2025 Uncategorised 0
hVIVO celebrates landmark deal highlighting its role in advancing influenza therapy

More: MSD to acquire Cidara after positive phase 2b trial results
Source: News
